Zevra Therapeutics (ZVRA) announced the appointment of Justin Renz as Chief Financial Officer, effective March 9, 2026. Renz most recently served as Chief Financial & Operations Officer at Ardelyx (ARDX)
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZVRA: